Enflonsia 105 mg/0.7 mL, Injektionslösung in einer Fertigspritze

7680701450019 CH-70145 Injektionslösung

Associated product:

ENFLONSIA 105 mg/0.7 mL sol inj 105 mg 1 pce

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
30/01/2026
Summary of Product Characteristics
Français
30/01/2026
Summary of Product Characteristics
Italien
30/01/2026

Detailed composition

Substance Quantity Type Category
clesrovimabum
105.0 MG Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
arginini hydrochloridum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
histidinum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 369.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2026

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
70145
Drug name
Enflonsia, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
J06BD10
Authorization status
Z
Dispensing category
A
First authorization
22/01/2026
Authorization expiration date
21/01/2031
IT Number
08.03.0.
Domain
Human medicine
Field of application
RSV-Prophylaxe

Package details

Description (FR)
ENFLONSIA 105 mg/0.7 mL sol inj 105 mg 1 pce
Description (DE)
ENFLONSIA 105 mg/0.7 mL Inj Lös 105 mg 1 Stk
Market launch
20/07/2026
Narcotic (BTM)
No

Other package sizes (1)

ENFLONSIA 105 mg/0.7 mL sol inj 105 mg 10 pce
10 FESP
GTIN: 7680701450026
View
Buy us a coffee Explore the data